|
|
|
| 13.09.2007 |
|
GeneBio's Phenyx Integrated with Institute for System Biology's TPP Geneva, Switzerland and Seattle, Washington, USA - September 13, 2007 - Geneva Bioinformatics (GeneBio) SA and the Institute for Systems Biology (ISB) today announced the successful integration of GeneBio's Phenyx MS data analysis platform into the ISB's Trans Proteomic Pipeline (TPP), an Open Source analysis platform for unified storage and analysis of tandem mass spectrometry data based on open XML file formats. This integration, that was rendered very straightforward thanks to Phenyx's increased flexibility and the wealth of import/export formats it accepts, brings TPP developers and users access to a powerful search engine while giving Phenyx users the freedom to automatically process results with a host of high-throughput proteomics analysis tools. Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio's renowned software platform for the identification and characterization of proteins and peptides from mass spectrometry data, specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment while offering a flexible user experience and an adaptable architecture to help instill confidence in results assessment. (http://phenyx.vital-it.ch/pwi) ISB's TPP was one of the earliest comprehensive tools suites to address the requirements of the proteomics community for standardized MS/MS data analysis and validation. Using TPP tools, each putative identification is assigned a probability of being correct and robust; global false discovery rates (FDRs) are calculated both at the spectrum and peptide level with PeptideProphet and at the protein level with ProteinProphet. "Phenyx is a major player in the mass spectrometry field; an increasing number of TPP users are requesting the ability to validate Phenyx search results using the TPP tools," said Dr. Eric Deutsch of the ISB. "Our goal is to make the TPP an invaluable part of the analysis process for as many users as possible by ensuring it works well with other industry tools; the integration of Phenyx fulfils user expectations and extends the functionality of the TPP. The integration of Phenyx will improve confidence levels in protein and peptide identifications for all its users." "This integration brings Phenyx users a wealth of functionalities while also broadening our market penetration," said Nasri Nahas, CEO of GeneBio. "Phenyx users can now automatically process their results into the TPP statistical validation pipeline via PeptideProphet and ProteinProphet, while publishing results via PeptideAtlas. These are only a few examples of what this integration brings to Phenyx users; looking at it from a different angle, we look forward to a plethora of new Phenyx users from our exposure in the TPP. This fantastic opportunity is perfectly congruent with GeneBio's increased effort to integrate Phenyx in major proteomics platforms and software in order to facilitate its accessibility to our ever growing client-base." For more information about Phenyx and its interaction with the TPP please go to www.phenyx-ms.com or contact us at Phenyx@genebio.com. To download the new version of the TPP and start using it with Phenyx now, please visit the following link: http://tools.proteomecenter.org/software.php About GeneBioGeneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing the life science community with world-class proteomics software that bridges the gap between information gathering and knowledge generation. Established in 1997, we focus our expertise on protein identification and characterization as well as proteome imaging, offering clients and partners a high degree of specialization essential to proteomics research. Close ties to academic peers and a thorough network of distribution and strategic partners give us both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community. For more information about GeneBio, please visit: www.genebio.com About the Institute for Systems Biology The Institute for Systems Biology (ISB) is an internationally renowned, non-profit research institute headquartered in Seattle and dedicated to the study and application of systems biology. Founded by Leroy Hood, Alan Aderem and Ruedi Aebersold, ISB seeks to unravel the mysteries of human biology and identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. ISB's systems approach integrates biology, computation and technological development, enabling scientists to analyze all elements in a biological system rather than one gene or protein at a time. Founded in 2000, the Institute has grown to 12 faculty and more than 200 staff members; an annual budget of more than $25 million; and an extensive network of academic and industrial partners. For more information about ISB, visit www.systemsbiology.org. GeneBio 連絡先: Institute for Systems Biology 連絡先: |